- MyndTec (MYTC) has closed a non-brokered private placement for gross proceeds of $572,199.00
- The company issued 762,932 units at $0.75 per unit
- The net proceeds of the offering will be used to fund corporate expenditures
- MyndTec is a Canadian medical technology company that develops non-invasive neurological and nervous system electrical stimulation therapeutics
- MyndTec Inc. (MYTC) opened trading at C$0.90
MyndTec (MYTC) has closed its previously announced non-brokered private placement for gross proceeds of $572,199.00.
The company issued 762,932 units at $0.75 per unit. Each unit consists of one common share and one share purchase warrant. Each warrant is exercisable to acquire one additional share at a price of $0.90 for a period of 36 months following the closing date of the offering.
The net proceeds of the offering will be used to fund corporate expenditures, sales and marketing.
MyndTec is a Canadian medical technology company dedicated to the development and commercialization of products that improve function, maximize independence and enhance the quality of life for individuals who have suffered an injury to the central nervous system as a result of stroke, spinal cord injury and certain traumatic brain injuries.
The company develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injuries specifically targeted to markets with large, growing and global patient populations.
MyndTec Inc. (MYTC) opened trading at C$0.90.